These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7039612)

  • 1. Defibrinating agents: effects on blood rheology, blood flow and vascular diseases in controlled studies.
    Lowe GD
    Bibl Haematol; 1981; (47):247-51. PubMed ID: 7039612
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled evaluation of drugs in chronic vascular disease.
    Trübestein G
    Angiology; 1981 Oct; 32(10):699-704. PubMed ID: 6173001
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodilution combined with defibrinogenation.
    Böhme H; Everts B
    Bibl Haematol; 1981; (47):165-72. PubMed ID: 7039611
    [No Abstract]   [Full Text] [Related]  

  • 7. [Defibrinating treatment in children with severe nephrotic syndrome].
    Grygalewicz J; Ostojska J
    Pediatr Pol; 1978 Apr; 53(4):531-6. PubMed ID: 652447
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The therapeutic effect of defibrase on patients with an acute stage of chronic cor pulmonale].
    Zhou YC; Weng XZ; Qiu HG
    Zhonghua Nei Ke Za Zhi; 1986 Jul; 25(7):404-6, 444. PubMed ID: 3542425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of various anti-platelet drugs and defibrinating agents on experimental glomerulonephritis in rats (author's transl)].
    Ogawa S; Naruse T
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):309-22. PubMed ID: 7031320
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of a rheologic therapy of microangiopathies].
    Ehrly AM
    Med Welt; 1975 Nov; 26(46):2092-3. PubMed ID: 1196100
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of defibrinating enzymes in the treatment of chronic ischemia of lower extremities].
    Malanowicz W; Liszewska D; Skarzyńska M; Tymińska K; Latallo ZS
    Pol Arch Med Wewn; 1977 Jul; 58(1):23-31. PubMed ID: 887461
    [No Abstract]   [Full Text] [Related]  

  • 13. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of retinal venous occlusions with a new defibrinating agent (Defibrase). Preliminary study].
    Gaudric A; Tolub O; Coscas G; Conard J; Samama M; Lelong F
    Bull Soc Ophtalmol Fr; 1982 Jan; 82(1):79-82. PubMed ID: 7049431
    [No Abstract]   [Full Text] [Related]  

  • 15. Defibrinogating therapy for peripheral circulatory disturbance in patients with vibration syndrome.
    Nasu Y
    Scand J Work Environ Health; 1986 Aug; 12(4 Spec No):272-6. PubMed ID: 3535061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytics and defibrinating agents].
    Vergoz D
    Phlebologie; 1975; 28(1):37-8. PubMed ID: 1202531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathy.
    Ringelstein EB; Mauckner A; Schneider R; Sturm W; Doering W; Wolf S; Maurin N; Willmes K; Schlenker M; Brückmann H
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1051-7. PubMed ID: 3063776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical impact of hemorheology on the treatment of chronic peripheral ischemia.
    Dormandy JA
    Angiology; 1981 Oct; 32(10):710-4. PubMed ID: 7325406
    [No Abstract]   [Full Text] [Related]  

  • 20. Defibrinogenation treatment in patients suffering from severe intermittent claudication - a controlled study.
    Martin M; Hirdes E; Auel H
    Thromb Res; 1976 Jul; 9(1):47-57. PubMed ID: 785691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.